Real World Use of Tocilizumab Biosimilar studY

Clinical trial NCT06247722 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06247722
Sponsor: Fresenius Kabi SwissBioSim GmbH
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Rheumatoid Arthritis

Start date: 2024-03-05
Primary completion: 2026-03-05
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.